ARCHIVES

National Cancer Policy Board will end in 2005, NCI to support a cancer forum at IOM.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: No Such Thing As Premature Data, Fisher Says- Only Immature Evaluation, Premature Application

June 20, 1980

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

July 27, 2012

Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher

June 13, 1980

Study Finds No Evidence That Statins Cut Cancer Risk

January 27, 2006

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

April 10, 1987

EORTC Places Same Number on Phase 2-3 Trials As In U.S.

December 12, 1986